Prostate Cancer Clinical Trials

A listing of Prostate Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 80 clinical trials
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

tumor cells
lymphoma
dabrafenib
palbociclib
remission
  • 6575 views
  • 08 Aug, 2022
  • 909 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

>Adenocarcinoma with variants of GU system (excluding prostate cancer) (closed to accrual 07/27/2018) Odontogenic malignant tumors Pancreatic neuroendocrine tumor (PNET) (formerly named

pheochromocytoma, malignant
carcinoid
pituitary
tumor cells
computed tomography
  • 6634 views
  • 10 Aug, 2022
  • 752 locations
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may …

diabetes
tumor cells
mitomycin
monoclonal antibodies
advanced melanoma
  • 162 views
  • 11 Aug, 2022
  • 415 locations
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

This phase II/III trial studies how well circulating tumor deoxyribonucleic acid (ctDNA) testing in the blood works in predicting treatment for patients with stage IIA colon cancer after surgery. ctDNA are circulating tumor cells that are shed by tumors into the blood. Finding ctDNA in the blood means that there …

fluorouracil
tumor cells
oxaliplatin
absolute neutrophil count
international normalized ratio
  • 0 views
  • 10 Aug, 2022
  • 594 locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

squamous cell carcinoma
tumor cells
crizotinib
pemetrexed
pembrolizumab
  • 1154 views
  • 08 Aug, 2022
  • 1029 locations
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

This phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (time being alive) and progression-free survival (time being alive without cancer) for patients with intermediate risk human papillomavirus (HPV) positive oropharynx cancer (throat cancer) that has …

  • 428 views
  • 11 Aug, 2022
  • 461 locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

tumor cells
insulin
monoclonal antibodies
cardiotoxic agents
pemetrexed
  • 322 views
  • 09 Aug, 2022
  • 771 locations
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Background Some people with prostate cancer have a rise in prostate-specific antigen (PSA). This can happen even after treatments like radiation and surgery

metastatic prostate cancer
nilutamide
prostate cancer metastatic
androgens
flutamide
  • 56 views
  • 08 Aug, 2022
  • 1 location
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

This exploratory study conducted under the RDRC program studies the biodistribution of 99mTc-PSMA-I&S in patients with prostate cancer who undergo pelvic lymph node dissection. Prostate

  • 0 views
  • 08 Aug, 2022
  • 1 location
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency

of life in men with prostate cancer who have undergone radical prostatectomy.

androgens
testosterone
prostatectomy
prostate specific antigen
serum testosterone
  • 0 views
  • 11 Aug, 2022
  • 3 locations